122 related articles for article (PubMed ID: 36549990)
1. Association of Relative Cerebral Blood Volume from Dynamic Susceptibility Contrast-Enhanced Perfusion MR with HER2 Status in Breast Cancer Brain Metastases.
Young JR; Ressler JA; Shiroishi MS; Mortimer JE; Schmolze D; Fitzgibbons M; Chen BT
Acad Radiol; 2023 Sep; 30(9):1816-1822. PubMed ID: 36549990
[TBL] [Abstract][Full Text] [Related]
2. Performance of enhancement on brain MRI for identifying HER2 overexpression in breast cancer brain metastases.
Young JR; Ressler JA; Mortimer JE; Schmolze D; Fitzgibbons M; Chen BT
Eur J Radiol; 2021 Nov; 144():109948. PubMed ID: 34534735
[TBL] [Abstract][Full Text] [Related]
3. Percentage signal intensity recovery: A step ahead of rCBV in DSC MR perfusion imaging for the differentiation of common neoplasms of brain.
Surendra KL; Patwari S; Agrawal S; Chadaga H; Nagadi A
Indian J Cancer; 2020; 57(1):36-43. PubMed ID: 31898591
[TBL] [Abstract][Full Text] [Related]
4. Differentiation of Glioblastoma and Solitary Brain Metastasis by Gradient of Relative Cerebral Blood Volume in the Peritumoral Brain Zone Derived from Dynamic Susceptibility Contrast Perfusion Magnetic Resonance Imaging.
She D; Xing Z; Cao D
J Comput Assist Tomogr; 2019; 43(1):13-17. PubMed ID: 30015801
[TBL] [Abstract][Full Text] [Related]
5. The role of dynamic susceptibility contrast-enhanced perfusion MR imaging in differentiating between infectious and neoplastic focal brain lesions: results from a cohort of 100 consecutive patients.
Floriano VH; Torres US; Spotti AR; Ferraz-Filho JR; Tognola WA
PLoS One; 2013; 8(12):e81509. PubMed ID: 24324699
[TBL] [Abstract][Full Text] [Related]
6. Dynamic contrast-enhanced susceptibility-weighted perfusion imaging of intracranial tumors: a study using a 3T MR scanner.
Sentürk S; Oğuz KK; Cila A
Diagn Interv Radiol; 2009 Mar; 15(1):3-12. PubMed ID: 19263367
[TBL] [Abstract][Full Text] [Related]
7. Dynamic susceptibility contrast (DSC) perfusion MRI in differential diagnosis between radionecrosis and neoangiogenesis in cerebral metastases using rCBV, rCBF and K2.
Muto M; Frauenfelder G; Senese R; Zeccolini F; Schena E; Giurazza F; Jäger HR
Radiol Med; 2018 Jul; 123(7):545-552. PubMed ID: 29508242
[TBL] [Abstract][Full Text] [Related]
8. Relative cerebral blood volume values to differentiate high-grade glioma recurrence from posttreatment radiation effect: direct correlation between image-guided tissue histopathology and localized dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging measurements.
Hu LS; Baxter LC; Smith KA; Feuerstein BG; Karis JP; Eschbacher JM; Coons SW; Nakaji P; Yeh RF; Debbins J; Heiserman JE
AJNR Am J Neuroradiol; 2009 Mar; 30(3):552-8. PubMed ID: 19056837
[TBL] [Abstract][Full Text] [Related]
9. Association of choline levels and tumor perfusion in brain metastases assessed with proton MR spectroscopy and dynamic susceptibility contrast-enhanced perfusion weighted MRI.
Huang BY; Kwock L; Castillo M; Smith JK
Technol Cancer Res Treat; 2010 Aug; 9(4):327-37. PubMed ID: 20626199
[TBL] [Abstract][Full Text] [Related]
10. Association of lesion contour and lesion composition on MR with HER2 status in breast cancer brain metastases.
Young JR; Ressler JA; Mortimer JE; Schmolze D; Fitzgibbons M; Chen BT
Magn Reson Imaging; 2023 Feb; 96():60-66. PubMed ID: 36423795
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.
Abrigo JM; Fountain DM; Provenzale JM; Law EK; Kwong JS; Hart MG; Tam WWS
Cochrane Database Syst Rev; 2018 Jan; 1(1):CD011551. PubMed ID: 29357120
[TBL] [Abstract][Full Text] [Related]
12. Posttreatment recurrence of malignant brain neoplasm: accuracy of relative cerebral blood volume fraction in discriminating low from high malignant histologic volume fraction.
Gasparetto EL; Pawlak MA; Patel SH; Huse J; Woo JH; Krejza J; Rosenfeld MR; O'Rourke DM; Lustig R; Melhem ER; Wolf RL
Radiology; 2009 Mar; 250(3):887-96. PubMed ID: 19244052
[TBL] [Abstract][Full Text] [Related]
13. Brain Gliomas: Multicenter Standardized Assessment of Dynamic Contrast-enhanced and Dynamic Susceptibility Contrast MR Images.
Anzalone N; Castellano A; Cadioli M; Conte GM; Cuccarini V; Bizzi A; Grimaldi M; Costa A; Grillea G; Vitali P; Aquino D; Terreni MR; Torri V; Erickson BJ; Caulo M
Radiology; 2018 Jun; 287(3):933-943. PubMed ID: 29361245
[TBL] [Abstract][Full Text] [Related]
14. Tumor recurrence versus treatment effects in glioma: A comparative study of three dimensional pseudo-continuous arterial spin labeling and dynamic susceptibility contrast imaging.
Xu Q; Liu Q; Ge H; Ge X; Wu J; Qu J; Xu K
Medicine (Baltimore); 2017 Dec; 96(50):e9332. PubMed ID: 29390403
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance imaging-based tumour perfusion parameters are biomarkers predicting response after radiation to brain metastases.
Jakubovic R; Sahgal A; Soliman H; Milwid R; Zhang L; Eilaghi A; Aviv RI
Clin Oncol (R Coll Radiol); 2014 Nov; 26(11):704-12. PubMed ID: 25023291
[TBL] [Abstract][Full Text] [Related]
16. Comparing perfusion metrics obtained from a single compartment versus pharmacokinetic modeling methods using dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade.
Law M; Young R; Babb J; Rad M; Sasaki T; Zagzag D; Johnson G
AJNR Am J Neuroradiol; 2006 Oct; 27(9):1975-82. PubMed ID: 17032878
[TBL] [Abstract][Full Text] [Related]
17. Comparison of dynamic susceptibility-weighted contrast-enhanced MR methods: recommendations for measuring relative cerebral blood volume in brain tumors.
Paulson ES; Schmainda KM
Radiology; 2008 Nov; 249(2):601-13. PubMed ID: 18780827
[TBL] [Abstract][Full Text] [Related]
18. Synthetic generation of DSC-MRI-derived relative CBV maps from DCE MRI of brain tumors.
Sanders JW; Chen HS; Johnson JM; Schomer DF; Jimenez JE; Ma J; Liu HL
Magn Reson Med; 2021 Jan; 85(1):469-479. PubMed ID: 32726488
[TBL] [Abstract][Full Text] [Related]
19. Systematic assessment of multi-echo dynamic susceptibility contrast MRI using a digital reference object.
Stokes AM; Semmineh NB; Nespodzany A; Bell LC; Quarles CC
Magn Reson Med; 2020 Jan; 83(1):109-123. PubMed ID: 31400035
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic examination performance by using microvascular leakage, cerebral blood volume, and blood flow derived from 3-T dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in the differentiation of glioblastoma multiforme and brain metastasis.
Server A; Orheim TE; Graff BA; Josefsen R; Kumar T; Nakstad PH
Neuroradiology; 2011 May; 53(5):319-30. PubMed ID: 20625709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
